Literature DB >> 21436621

Hydrogel-siRNA for cancer therapy.

Sundaram Ramakrishnan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436621      PMCID: PMC3100633          DOI: 10.4161/cbt.11.9.15465

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  9 in total

Review 1.  Contrast echocardiography: evidence for clinical use.

Authors:  Vinay Kumar Bhatia; Roxy Senior
Journal:  J Am Soc Echocardiogr       Date:  2008-03-10       Impact factor: 5.251

Review 2.  Optimizing siRNA delivery to the genital mucosa.

Authors:  Joseph A Katakowski; Deborah Palliser
Journal:  Discov Med       Date:  2011-02       Impact factor: 2.970

3.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.

Authors:  Philip K Lim; Sarah A Bliss; Shyam A Patel; Marcelo Taborga; Meneka A Dave; Larissa A Gregory; Steven J Greco; Margarette Bryan; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

4.  Chitosan hydrogel for localized gene silencing.

Authors:  Hee Dong Han; Edna M Mora; Ju Won Roh; Masato Nishimura; Sun Joo Lee; Rebecca L Stone; Menashe Bar-Eli; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2011-05-01       Impact factor: 4.742

5.  Strategies for tumor-directed delivery of siRNA.

Authors:  Ezharul Hoque Chowdhury
Journal:  Expert Opin Drug Deliv       Date:  2011-02-11       Impact factor: 6.648

Review 6.  RNA interference in the clinic: challenges and future directions.

Authors:  Chad V Pecot; George A Calin; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

7.  Functional microRNA is transferred between glioma cells.

Authors:  Mark Katakowski; Benjamin Buller; Xinli Wang; Thomas Rogers; Michael Chopp
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

Review 8.  Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic.

Authors:  Rupesh Dash; Belal Azab; Xue-Ning Shen; Upneet K Sokhi; Siddik Sarkar; Zhao-zhong Su; Xiang-Yang Wang; Pier Paolo Claudio; Paul Dent; Igor P Dmitriev; David T Curiel; Steven Grant; Devanand Sarkar; Paul B Fisher
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

9.  Localized, targeted, and sustained siRNA delivery.

Authors:  Melissa D Krebs; Eben Alsberg
Journal:  Chemistry       Date:  2011-02-21       Impact factor: 5.236

  9 in total
  5 in total

Review 1.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

Review 2.  Integration of microbubbles with biomaterials in tissue engineering for pharmaceutical purposes.

Authors:  Javad Esmaeili; Farnoush Sadat Rezaei; Farzaneh Mahmoudi Beram; Abolfazl Barati
Journal:  Heliyon       Date:  2020-06-17

Review 3.  siRNA Targeting and Treatment of Gastrointestinal Diseases.

Authors:  Rachel Chevalier
Journal:  Clin Transl Sci       Date:  2019-08-05       Impact factor: 4.689

4.  Chitosan hydrogel as siRNA vector for prolonged gene silencing.

Authors:  Zhiwei Ma; Chuanxu Yang; Wen Song; Qintao Wang; Jørgen Kjems; Shan Gao
Journal:  J Nanobiotechnology       Date:  2014-06-19       Impact factor: 10.435

Review 5.  Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.

Authors:  Mohamed Shehata Draz; Binbin Amanda Fang; Pengfei Zhang; Zhi Hu; Shenda Gu; Kevin C Weng; Joe W Gray; Fanqing Frank Chen
Journal:  Theranostics       Date:  2014-06-11       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.